{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:53:44Z","timestamp":1791118424393,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":541,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p>Hepatosplenic \u03b3\u03b4<jats:sup>+<\/jats:sup> T\u2010cell lymphoma represents a rare neoplasm of post\u2010thymic phenotype, characterized by an aggressive clinical course and a poor response to conventional chemotherapy. In the present study, we have examined the cytotoxic effects of the purine analogue 2\u2032\u2010deoxycoformycin (dCF) on cultured mononuclear cells and purified \u03b3\u03b4<jats:sup>+<\/jats:sup> tumour cells from bone marrow or peripheral blood of four patients with hepatosplenic \u03b3\u03b4<jats:sup>+<\/jats:sup> T\u2010cell lymphoma. At a concentration of 10\u2003\u00b5<jats:sc>m<\/jats:sc>, dCF, in the presence of 2\u2032\u2010deoxyadenosine (dAdo), displayed an early and selective cytotoxic effect on \u03b3\u03b4<jats:sup>+<\/jats:sup> tumour T cells. After 48\u2003h of <jats:italic>in vitro<\/jats:italic> exposure to dCF, the absolute number of viable CD3<jats:sup>+<\/jats:sup>\/\u03b3\u03b4<jats:sup>+<\/jats:sup> tumour T cells was reduced by more than 90% in all samples with respect to control cultures, with absolute counts of viable CD3<jats:sup>+<\/jats:sup>\/\u03b1\u03b2<jats:sup>+<\/jats:sup> lymphocytes being reduced only by 6\u201340% of the initial cell input. Analysis of cultures after 5\u2003d of exposure to dCF plus dAdo revealed the persistence of normal CD3<jats:sup>+<\/jats:sup>\/\u03b1\u03b2<jats:sup>+<\/jats:sup> T cells, which accounted, however, for only 20\u201325% of the initial cell input. Accordingly, the combination of dCF (10\u2013100\u2003\u00b5<jats:sc>m<\/jats:sc>) plus dAdo was able to induce a dose\u2010dependent inhibition of clonogenic growth and [<jats:sup>3<\/jats:sup>H]\u2010thymidine incorporation in purified CD3<jats:sup>+<\/jats:sup>\/CD4<jats:sup>\u2212<\/jats:sup>\/CD8<jats:sup>\u2212<\/jats:sup>\u03b3\u03b4<jats:sup>+<\/jats:sup> tumour cells. We also report that one patient with hepatosplenic \u03b3\u03b4<jats:sup>+<\/jats:sup> T\u2010cell lymphoma in terminal leukaemic phase showed a striking haematological response to single\u2010agent dCF given as fourth\u2010line treatment. In particular, the selective clearance of \u03b3\u03b4<jats:sup>+<\/jats:sup> tumour T cells in peripheral blood and bone marrow was observed starting after the second course of treatment. Our results suggest that dCF may represent a potentially active drug for the management of this aggressive form of T\u2010cell lymphoma.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02129.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:25:46Z","timestamp":1047363946000},"page":"188-196","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["<i>In vitro<\/i> and <i>in vivo<\/i> effects of 2\u2032\u2010deoxycoformycin (Pentostatin) on tumour cells from human \u03b3\u03b4<sup>+<\/sup> T\u2010cell malignancies"],"prefix":"10.1111","volume":"110","author":[{"given":"Donatella","family":"Aldinucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalisa","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorina","family":"Zagonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rupolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(77)90192-7"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.6.461"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346040-00006"},{"key":"e_1_2_6_5_1","first-page":"934","article-title":"DNA strand breaks induced in human T\u2010lymphocytes by the combination of deoxyadenosine and deoxycoformycin","volume":"44","author":"Brox L.","year":"1984","journal-title":"Cancer Research"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.121.5.1726","article-title":"Differential sensitivity of human leukemic T\u2010cell lines and B\u2010cell lines to growth inhibition by deoxyadenosine","volume":"121","author":"Carson D.A.","year":"1978","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_7_1","first-page":"S103","article-title":"Clinical experience with 2\u2032\u2010deoxycoformicin","volume":"38","author":"Catovsky D.","year":"1996","journal-title":"Hematology and Cellular Therapy"},{"key":"e_1_2_6_8_1","first-page":"177","article-title":"Peripheral T\u2010cell and NK\u2010cell neoplasms: an integrated approach to diagnosis","volume":"12","author":"Chan J.K.C.","year":"1999","journal-title":"Modern Pathology"},{"key":"e_1_2_6_9_1","first-page":"S27","article-title":"New prospects in the treatment of indolent lymphomas with purine analogues","volume":"4","author":"Cheson B.D.","year":"1998","journal-title":"Cancer Journal from Scientific American"},{"key":"e_1_2_6_10_1","first-page":"95","volume-title":"Nucleoside Analogs in Cancer Therapy","author":"Cheson B.D.","year":"1997"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.1.472"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T\u2010cell lymphoma: a distinct clinicopathologic entity of cytotoxic \u03b3\u03b4 T\u2010cell origin","volume":"88","author":"Cooke C.B.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.4.565"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.423"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5699(96)10067-0"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.4049\/jimmunol.143.8.2480","article-title":"Distribution of T cells bearing different forms of the T cell receptor \u03b3\/\u03b4 in normal and pathological human tissues","volume":"143","author":"Falini B.","year":"1989","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.11.2213.2213"},{"key":"e_1_2_6_18_1","first-page":"141","article-title":"Human granulocyte\u2013macrophage colony\u2010stimulating factor supports the clonogenic growth of B\u2010lineage acute lymphoblastic leukemias expressing myeloid antigens","volume":"3","author":"Gattei V.","year":"1997","journal-title":"Cytokines, Cellular and Molecular Therapy"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01285.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060510"},{"key":"e_1_2_6_21_1","first-page":"617","article-title":"Expression of the alpha\/beta and gamma\/delta T\u2010cell receptors in 57 cases of peripheral T\u2010cell lymphomas. Identification of a subset of gamma\/delta T\u2010cell lymphomas","volume":"137","author":"Gaulard P.","year":"1990","journal-title":"American Journal of Pathology"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.003225"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008377724139"},{"key":"e_1_2_6_25_1","first-page":"S8","article-title":"World Health Organization classification of neoplastic diseases of the hemopoietic and lymphoid tissues. A progress report","volume":"111","author":"Jaffe E.S.","year":"1999","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006100900082"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb01963.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058439"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90179-1"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2588"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000227554"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1998.tb01571.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5676-9_43"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.19.8884"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0320(19980215)34:1<30::aid-cyto5>3.0.co;2-i"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(86)90029-9"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90176-3"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111710"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199506000-00013"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-8559-2_60"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02129.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02129.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02129.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:24:53Z","timestamp":1695828293000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02129.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02129.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02129.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}